1.00 / AMA PRA Category 1 CreditTM 1.00 / CE for Nurse Practitioners (0.30 pharmacology hours)
This activity is provided by Global Education Group. Paradigm Medical Communications, LLC is the educational partner.
This activity is supported by an educational grant from Seattle Genetics, Inc.
During this webinar, a national expert in the management of patients with CD30-positive lymphomas discusses the spectrum of CD30-positive lymphomas; when CD30 testing should be performed; the role of the pathologist in the management of CD30-positive lymphomas; the mechanism of action of antibody-drug conjugates and their clinical relevance; safety and efficacy profiles of antibody-drug conjugates; and key data from late-phase clinical trials. An animated mechanism-of-action video is included to depict the antibody-drug conjugates used in the treatment of CD30-positive lymphomas. The activity also includes several diagnostic and treatment case scenarios.
This activity has been designed to address the educational needs of physicians, PAs, and nurse practitioners within the specialties of oncology, hematology, hematology/oncology, and pathology. This activity will also be of benefit to other healthcare providers interested in the management of patients with CD30-positive lymphomas, including pharmacists and oncology nurses.
Upon proper completion of this activity, participants should be better able to:
Review the role of CD30 testing in the diagnosis of each of the subtypes of CD30-positive lymphomas
Describe the role of the pathologist in diagnosing CD30-positive lymphomas and the tests used in CD30 determination
Explain the utility of CD30-targeted antibody drug conjugates in treating CD30-positive lymphomas based on the mechanism of action, efficacy, toxicities, and late-phase clinical trial results
Conflict Of Interest Disclosure Policy
Global Education Group (Global) and Paradigm Medical Communications, LLC (Paradigm) requires instructors, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global and Paradigm for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CE activity:
Faculty Steven M. Horwitz, MD Associate Attending Physician Department of Medicine Memorial Sloan Kettering Cancer Center New York, NY
Dr. Horwitz has the following financial relationships to disclose:
Ratesh Khillan, MD Interfaith Medical Center Brooklyn, NY
Dr. Khillan has no financial relationships to disclose.
Steering Committee Steven T. Rosen, MD (Chair) Provost and Chief Scientific Officer Director, Comprehensive Cancer Center and Beckman Research Institute Irell & Manella Cancer Center Director’s Distinguished Chair City of Hope Duarte, CA
Dr. Rosen has no financial relationships to disclose.
Keri A. Halsema, NP Nurse Practitioner Hematology-Oncology/Bone Marrow Transplant Department University of Colorado Hospital Aurora, CO
Ms. Halsema has no financial relationships to disclose.
Eric D. Hsi, MD Professor of Pathology Cleveland Clinic Lerner College of Medicine Section Head, Hematopathology Chair, Department of Laboratory Medicine Robert J. Tomsich Pathology and Laboratory Medicine Institute Cleveland Clinic Cleveland, OH
Dr. Hsi has the following financial relationships to disclose:
Research Support: AbbVie Inc.; Cellerant Therapeutics, Inc.; Eli Lilly and Company
Advisory Board: Celgene Corporation; HTG Molecular Diagnostics, Inc.
Honoraria: Seattle Genetics, Inc
Accredited Provider Disclosure
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CE activity:
Amanda Glazer, PhD, Kristen Delisi, and Laura Gilsdorf have no financial relationships to disclose.
Paradigm Medical Communications, LLC staff members have no financial relationships to disclose.
AMA PRA Category 1 Credit(s)TM
Global Education Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
This CME/CE activity complies with all requirements of the federal Physician Payment Sunshine Act. If a reportable event is associated with this activity, the accredited provider managing the program will provide the appropriate physician data to the Open Payments database.
Global Education Group designates this enduring material for a maximum of 1.00 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
PA Continuing Education
AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 CreditTM from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 1.00 Category 1 credits for completing this activity.
CE for Nurse Practitioners
Global Education Group is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 110121.
This activity is accredited for 1.00 contact hour(s) which includes 0.30 hour(s) of pharmacology. Activity ID #2137E.
This activity was planned in accordance with AANP CE Standards and Policies.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global and Paradigm do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Signed statements of informed consent granting permission for use have been obtained for all photographs and videos in which an individual can be identified.
To receive a CE certificate of participation, participants must:
Follow the "Start Activity" button to go to the Paradigm Medical Communications website, where you will complete the pretest.
View the online activity in its entirety.
Complete and submit the online post-test and evaluation. You must answer 70% of the post-test questions correctly to earn credit. You will have unlimited opportunities to successfully complete the post-test.
A certificate of participation will be available for download/printing immediately following your successful completion of the post-test and evaluation. Your certificate will be saved on the Paradigm Medical Communications website and will not be available in your myCME CME History.
There is no fee required for participation in this activity.
For questions regarding CE credit, contact the Paradigm CME Department at (845) 398-5949.
Technical Support: If you have any technical problems or playback issues, please email Paradigm at firstname.lastname@example.org.
Disclaimer The materials provided for this activity are for informational purposes only, and should not be used for diagnosis or treatment of a health problem without consulting a licensed medical professional. Any views or opinions presented are solely those of the faculty, and do not necessarily represent those of Global Education Group or Paradigm Medical Communications, LLC. References to any entity, product, service, or source of information on this website should not be considered an endorsement, either direct or implied, by Global or Paradigm. Global and Paradigm accept no liability for the content referenced in this activity.
Security/safeguarding personal information This website has physical and procedural safeguards in place to prevent unauthorized access to personal information used to access this website.
Collection and use of your personal information The submission of certain personally identifiable information is necessary to award and track the credits participants may earn after completing the program. Required items include first name, last name, degree, and email address. These items are necessary. Participants are also required to complete an evaluation of the CME activity. All evaluative information submitted is collected and retained, and used by Global and Paradigm to continuously improve the learning experience.
Global Education Group and Paradigm Medical Communications, LLC do not transfer, sell, or share personal information with outside parties. Global Education Group and Paradigm Medical Communications, LLC will not otherwise disclose personal information unless required to in a legal process. Global and Paradigm staff members review individual test results to the extent necessary to record and track participants’ credits.